Skip to Main Content

Paper Details

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.
Circulation
8
2023
Author NameAffiliation
Alan S GoKaiser Permanente Bernard J. Tyson School of Medicine
Alan S GoKaiser Permanente Northern California
Alan S GoUniversity of California san francisco
  • 1 - 3

Datasets

Release 1.2